Compare FNF & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNF | ICLR |
|---|---|---|
| Founded | 1847 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 13.1B |
| IPO Year | 2005 | 2001 |
| Metric | FNF | ICLR |
|---|---|---|
| Price | $40.41 | $185.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 18 |
| Target Price | $55.00 | ★ $187.76 |
| AVG Volume (30 Days) | ★ 2.3M | 858.3K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | ★ 5.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.98 | N/A |
| Revenue | ★ $14,445,000,000.00 | N/A |
| Revenue This Year | $2.61 | N/A |
| Revenue Next Year | $3.01 | $3.63 |
| P/E Ratio | $20.85 | ★ $12.91 |
| Revenue Growth | ★ 5.58 | N/A |
| 52 Week Low | $37.88 | $66.57 |
| 52 Week High | $60.37 | $203.91 |
| Indicator | FNF | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 63.96 |
| Support Level | $37.88 | $157.92 |
| Resistance Level | $47.40 | $191.00 |
| Average True Range (ATR) | 0.99 | 8.68 |
| MACD | 0.44 | 2.16 |
| Stochastic Oscillator | 59.55 | 81.23 |
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.